ChromTalks: The Benefit of Hindsight in Chromatography
***Thursday and Friday May 13-14 | May 20-21, 2021*** In the relaxed and unconventional talks in this symposium, highly experienced speakers from industry and academia will impart key learnings from their long experience with chromatography—from heroic failures that have taught them valuable lessons, to moments of inspirational serendipity, and everything in between. CHROMTalks will deliver lifetimes of learning in condensed form, covering topics across implementation, troubleshooting, and method development of analytical techniques. Time spent at CHROMTalks will pay back as soon as you enter your laboratory! ***Available On Demand Until May 21, 2022***
Back to Basics for Bio Chromatography – Reversed Phase LC Method Development for mAbs
April 7th 2021*** Wednesday, April 7, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST*** Are you getting the most out of your reversed-phased chromatography for mAb characterization? Wish you could deliver better methods that benefit both R&D efforts and requirements for release assays? *On demand available after final airing until Apr. 7, 2022*
Biopharmaceutical Analysis Focus 2020: A Virtual Symposium
November 18th 2020***Live Dates:Day 1, Wednesday, November 18, 2020 9am–11:30am EST | 2pm – 3:30pm GMT | 3pm-4:30pm CET Day 2, Thursday, November 19, 2020 9am–11:30am EST | 2pm – 3:30pm GMT | 3pm-4:30pm CET ***Biopharmaceutical analysis is a fast-paced and constantly evolving field, and chromatographers play a pivotal role. This two-day virtual event, focusing on cutting-edge trends, has been organized by The Chromatographic Society (“ChromSoc”) in collaboration with LCGC and features talks from top analytical chemists working in biopharmaceutical analysis.***On demand available after final airing until Nov. 19, 2021***
Overcoming Separation Challenges in Biological Drug Development
October 23rd 2019The landscape for new biological drug development continues to evolve in complexity. With biosimilars entering the market and originator products coming off patent, the competitive race for market dominance is reliant on!
Overcoming Separation Challenges in Biological Drug Development
October 23rd 2019The landscape for new biological drug development continues to evolve in complexity. With biosimilars entering the market and originator products coming off patent, the competitive race for market dominance is reliant on!